Summary of computation of basic and diluted net loss per share |
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and six months ended July 31, 2021 and 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands, except share and per share data) |
|
|
(in thousands, except share and per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(84,938 |
) |
|
$ |
(35,287 |
) |
|
$ |
(2,649 |
) |
|
$ |
(65,385 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accretion of beneficial conversion feature of redeemable convertible preferred stock |
|
|
— |
|
|
|
(58,625 |
) |
|
|
— |
|
|
|
(58,625 |
) |
Cumulative dividends on redeemable convertible preferred stock |
|
|
— |
|
|
|
— |
|
|
|
(4,292 |
) |
|
|
— |
|
Deemed dividends attributable to vested option holders |
|
|
— |
|
|
|
— |
|
|
|
(51,855 |
) |
|
|
— |
|
Deemed dividends attributable to common stock warrant holders |
|
|
— |
|
|
|
— |
|
|
|
(110,635 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders - Basic |
|
|
(84,938 |
) |
|
|
(93,912 |
) |
|
|
(169,431 |
) |
|
|
(124,010 |
) |
Gain attributable to earnout shares issued |
|
|
— |
|
|
|
— |
|
|
|
(84,420 |
) |
|
|
— |
|
Change in fair value of dilutive warrants |
|
|
(7,427 |
) |
|
|
— |
|
|
|
(53,540 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders - Diluted |
|
$ |
(92,365 |
) |
|
$ |
(93,912 |
) |
|
$ |
(307,391 |
) |
|
$ |
(124,010 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
312,465,016 |
|
|
|
13,537,501 |
|
|
|
266,473,703 |
|
|
|
12,822,481 |
|
Weighted-average unvested restricted shares and shares subject to repurchase |
|
|
(237,490 |
) |
|
|
(68,824 |
) |
|
|
(276,221 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - Basic |
|
|
312,227,526 |
|
|
|
13,468,677 |
|
|
|
266,197,482 |
|
|
|
12,822,481 |
|
Earnout Shares under the treasury stock method |
|
|
— |
|
|
|
— |
|
|
|
7,464,203 |
|
|
|
— |
|
Public and Private Placement Warrants under the treasury stock method |
|
|
1,374,574 |
|
|
|
— |
|
|
|
1,915,315 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - Diluted |
|
|
313,602,100 |
|
|
|
13,468,677 |
|
|
|
275,577,000 |
|
|
|
12,822,481 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share - Basic |
|
$ |
(0.27 |
) |
|
$ |
(6.97 |
) |
|
$ |
(0.64 |
) |
|
$ |
(9.67 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share - Diluted |
|
$ |
(0.29 |
) |
|
$ |
(6.97 |
) |
|
$ |
(1.12 |
) |
|
$ |
(9.67 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended January 31, 2021, 2020, and 2019:
|
|
|
|
|
|
|
|
|
|
|
| |
(in thousands, except share and per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders |
|
$ |
(274,200 |
) |
|
$ |
(134,327 |
) |
|
$ |
(108,087 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted |
|
|
15,116,763 |
|
|
|
8,893,787 |
|
|
|
4,342,517 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share attributable to common stockholders, basic and diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary of computation of diluted net loss per share |
The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows:
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
Redeemable convertible preferred stock (on an as-converted basis) |
|
|
— |
|
|
|
192,469,995 |
|
Options to purchase common stock |
|
|
26,401,717 |
|
|
|
39,463,877 |
|
|
|
|
4,017,149 |
|
|
|
— |
|
Unvested early exercised common stock options |
|
|
211,464 |
|
|
|
102,781 |
|
Common stock and preferred stock warrants |
|
|
37,075,846 |
|
|
|
38,193,342 |
|
|
|
|
|
|
|
|
|
|
Total potentially dilutive common share equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary of Computation of Diluted Net Loss Per Share |
|
The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable convertible preferred stock (on an as-converted basis) |
|
|
193,037,715 |
|
|
|
170,686,661 |
|
|
|
168,052,012 |
|
Options to purchase common stock |
|
|
30,167,178 |
|
|
|
34,883,465 |
|
|
|
31,662,022 |
|
Unvested restricted common stock |
|
|
— |
|
|
|
166,100 |
|
|
|
564,740 |
|
Unvested early exercised common stock options |
|
|
371,193 |
|
|
|
58,830 |
|
|
|
58,971 |
|
Redeemable convertible preferred stock warrants (on an as-converted basis) |
|
|
2,358,546 |
|
|
|
2,358,546 |
|
|
|
2,358,546 |
|
|
|
|
36,402,515 |
|
|
|
14,051,462 |
|
|
|
13,173,245 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total potentially dilutive common share equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|